Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03787264
Brief Title: Sequential Regimen of Bendamustin-Debulking Followed by Obinutuzumab, Acalabrutinib and Venetoclax in Patients With Relapsed/Refractory CLL (CLL2-BAAG)

First Submitted : December 20, 2018
First Submitted that Met QC Criteria : December 22, 2018
First Posted : December 25, 2018 (Estimate)

Last Update Submitted that Met QC Criteria : January 22, 2019
Last Update Posted : January 24, 2019